Correlation of Zinc Levels on C-Reactive Protein Among Advanced-Stage Non-Small Cell Lung Cancer Patients
DOI:
https://doi.org/10.36497/jri.v45i1.603Keywords:
CRP, NSCLC, ZincAbstract
Background: Lung cancer is a leading cause of malignancy and mortality. Zinc and C-reactive proteins are known to affect lung cancer progression. However, inconsistent findings between zinc levels on plasma CRP levels were reported. This study aimed to determine the correlation between serum zinc and CRP levels in patients with advanced-stage non-small cell lung cancer (NSCLC)
Methods: A cross-sectional study was conducted in the Regional Hospital of Doris Sylvanus Palangkaraya between January and April 2023. Thirty-five lung cancer patients were included. The blood specimen was analyzed for serum Zinc and CRP. Spearman's correlation test was used to analyze the data.
Results: The zinc level was dominantly normal or low (71.4%), with a mean of 65.57 ug/dL. Most subjects have elevated CRP, with higher CRP in the deficiency zinc group (96.64 vs. 68.89 mg/L). However, no significant correlation was found between serum zinc and CRP levels (P=0.160; r=0.173).
Conclusion: Serum zinc levels were not proven statistically correlated with inflammatory markers (CRP), particularly in non-small lung cancer patients.
Downloads
References
1. World Cancer Research Fund. Lung Cancer Statistics. 2022. Available from: https://www.wcrf.org/preventing-cancer/cancer-statistics/lung-cancer-statistics/ [Last accessed: 1/10/2023].
2. World Life Expectancy. Lung Cancers in Indonesia. 2020. Available from: https://www.worldlifeexpectancy.com/indonesia-lung-cancers [Last accessed: 1/10/2023].
3. Malhotra J, Malvezzi M, Negri E, et al. Risk factors for lung cancer worldwide. European Respiratory Journal 2016;48(3):889–902.
4. Centers for Disease Control and Prevention. What Are the Symptoms of Lung Cancer. 2023. Available from: https://www.cdc.gov/lung-cancer/?CDC_AAref_Val=https://www.cdc.gov/cancer/lung/basic_info/symptoms.htm [Last accessed: 1/10/2023].
5. Chen L, Deng H, Cui H, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018;9(6):7204–18.
6. He G, Karin M. NF-κB and STAT3- key players in liver inflammation and cancer. Cell Res 2011;21(1):159–68.
7. Pahwa R, Goyal A, Jialal I. Chronic Inflammation Continuing Education Activity. In: Chronic Inflammation StatPearls Publishing: Treasure Island (FL); 2023.
8. Mousavi SM, Djafarian K, Mojtahed A, et al. The effect of zinc supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials. Eur J Pharmacol 2018;834:10–6.
9. Wang Y, Sun Z, Li A, et al. Association between serum zinc levels and lung cancer: A meta-analysis of observational studies. World J Surg Oncol 2019;17(1):78.
10. Wang J, Zhao H, Xu Z, et al. Zinc dysregulation in cancers and its potential as a therapeutic target. Cancer Biol Med 2020;17(3):612–25.
11. Bao B, Prasad AS, Beck FWJ, et al. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: A potential implication of zinc as an atheroprotective agent. American Journal of Clinical Nutrition 2010;91(6):1634–41.
12. Harle A, Molassiotis A, Buffin O, et al. A cross sectional study to determine the prevalence of cough and its impact in patients with lung cancer: A patient unmet need. BMC Cancer 2020;20(1):9.
13. Ekemen Keleş Y, Yılmaz Çiftdoğan D, Çolak A, et al. Serum zinc levels in pediatric patients with COVID-19. Eur J Pediatr 2022;181(4):1575–84.
14. Adriani M, Wirjatmadi B, Utermohlen V. CRP and IGA Levels in Wasting Children under Five Based on Zinc and Retinol Level. In: 2012 International Conference on Nutrition and Food Sciences IACSIT Press: Singapore; 2012.
15. Craig GM, Evans SJ, Brayshaw BJ. An inverse relationship between serum zinc and C-reactive protein levels in acutely ill elderly hospital patients. Postgrad Med J 1990;66(782):1025–8.
16. Haneen Abdul-ameer Haji, Maitham Ali Al-Rikabi. The relationship between serum level of c-reactive protein and zinc in COVID-19 patients. J Pharm Negat Results 2022;13(Special Issue 8):446–55.
17. Sattar N, Scott HR, McMillan DC, et al. Acute-phase reactants and plasma trace element concentrations in non- small cell lung cancer patients and controls. Nutr Cancer 1997;28(3):308–12.
18. Mcdonald CM, Suchdev PS, Krebs NF, et al. Adjusting plasma or serum zinc concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. American Journal of Clinical Nutrition 2020;111(4):927–37.
19. Alam MP, Sunardi D, Rinaldi I. Correlation between zinc intake and zinc serum levels with c-reactive protein level in head and neck cancer patients. World Nutrition Journal 2019;2(2):9–14.
20. Sugimoto R, Lee L, Tanaka Y, et al. Zinc deficiency as a general feature of cancer: A review of the literature. Biol Trace Elem Res 2024;202(5):1937–47.
21. Jia PL, Zhang C, Yu JJ, et al. The risk of lung cancer among cooking adults: A meta-analysis of 23 observational studies. J Cancer Res Clin Oncol 2018;144(2):229–40.
22. Mundt KA, Dell LD, Crawford L, et al. Cancer risk associated with exposure to bitumen and bitumen fumes: An updated systematic review and meta-analysis. J Occup Environ Med 2018;60(1):e6–e54.
23. Allin KH, Nordestgaard BG, Flyger H, et al. Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: A cohort study. Breast Cancer Research 2011;13(3):R55.
24. Hart PC, Rajab IM, Alebraheem M, et al. C-reactive protein and cancer—Diagnostic and therapeutic insights. Front Immunol 2020;11:595835.
25. Sanikini H, Yuan JM, Butler LM, et al. Body mass index and lung cancer risk: A pooled analysis based on nested case-control studies from four cohort studies. BMC Cancer 2018;18(1):220.
26. Thurner EM, Krenn-Pilko S, Langsenlehner U, et al. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy. Eur J Cancer 2015;51(5):610–9.
27. Giaquinto AN, Miller KD, Tossas KY, et al. Cancer statistics for African American/Black people 2022. CA Cancer J Clin 2022;72(3):202–29.
28. Hussain A, Jiang W, Wang X, et al. Mechanistic impact of zinc deficiency in human development. Front Nutr 2022;9:717064.
29. Andarini S, Syahruddin E, Aditya N, et al. Indonesian Society of Respirology (ISR) consensus statement on lung cancer screening and early detection in Indonesia. Jurnal Respirologi Indonesia 2023;43(2):144–50.
30. Venturelli S, Leischner C, Helling T, et al. Minerals and cancer: Overview of the possible diagnostic value. Cancers (Basel) 2022;14(5):1256.
31. Molassiotis A, Smith JA, Mazzone P, et al. Symptomatic treatment of cough among adult patients with lung cancer. Chest 2017;151(4):861–74.
32. Myers DJ, Wallen JM. Continuing Education Activity. In: Lung Adenocarcinoma StatPearls Publishing: Treasure Island (FL); 2023.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Nugroho Eko prasetyo, Haryati Haryati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
